celecoxib has been researched along with Actinic Keratosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laquer, V | 1 |
| Dellinger, RW | 1 |
| Mannering, I | 1 |
| Garcia, AG | 1 |
| Abraham, V | 1 |
| Pavlis, J | 1 |
| Liu-Smith, F | 1 |
| De Feraudy, S | 1 |
| Meyskens, FL | 2 |
| Kelly, KM | 1 |
| McLaren, CE | 1 |
| Elmets, CA | 1 |
| Viner, JL | 1 |
| Pentland, AP | 1 |
| Cantrell, W | 1 |
| Lin, HY | 1 |
| Bailey, H | 1 |
| Kang, S | 1 |
| Linden, KG | 1 |
| Heffernan, M | 1 |
| Duvic, M | 1 |
| Richmond, E | 1 |
| Elewski, BE | 1 |
| Umar, A | 1 |
| Bell, W | 1 |
| Gordon, GB | 1 |
| Liebman, TN | 1 |
| Stein, JA | 1 |
| Polsky, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II/III Randomized, Double-Blind, Placebo-Controlled Clinical Trial Of Celecoxib In Subjects With Actinic Keratoses[NCT00027976] | Phase 2/Phase 3 | 0 participants (Actual) | Interventional | 2001-12-31 | Withdrawn | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for celecoxib and Actinic Keratosis
| Article | Year |
|---|---|
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous | 2010 |
3 other studies available for celecoxib and Actinic Keratosis
| Article | Year |
|---|---|
12-Hydroxyeicosatetraenoic acid levels are increased in actinic keratoses and squamous cell carcinoma.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Biopsy; Carcinoma, Squamous Cell; Celecoxib; Chemopreven | 2018 |
Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy?
Topics: Adenoma; Anticarcinogenic Agents; Breast Neoplasms; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; | 2010 |
Cyclo-oxygenase-2 inhibitors for chemoprevention of nonmelanoma skin cancer: is there a role for these agents?
Topics: Animals; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase 2 Inhibitors; Cy | 2013 |